Jung M - Search Results

1

Pyridylalanine-containing hydroxamic acids as selective HDAC6 inhibitors.

Schäfer S, Saunders L, Schlimme S, Valkov V, Wagner JM, Kratz F, Sippl W, Verdin E, Jung M. Schäfer S, et al. Among authors: jung m. ChemMedChem. 2009 Feb;4(2):283-90. doi: 10.1002/cmdc.200800196. ChemMedChem. 2009. PMID: 19090524

2

Inhibitors of histone deacetylase as new anticancer agents.

Jung M. Jung M. Curr Med Chem. 2001 Oct;8(12):1505-11. doi: 10.2174/0929867013372058. Curr Med Chem. 2001. PMID: 11562279 Review.

3

Structure-activity relationships on phenylalanine-containing inhibitors of histone deacetylase: in vitro enzyme inhibition, induction of differentiation, and inhibition of proliferation in Friend leukemic cells.

Wittich S, Scherf H, Xie C, Brosch G, Loidl P, Gerhäuser C, Jung M. Wittich S, et al. Among authors: jung m. J Med Chem. 2002 Jul 18;45(15):3296-309. doi: 10.1021/jm0208119. J Med Chem. 2002. PMID: 12109913

4

Nonisotopic substrate for assaying both human zinc and NAD+-dependent histone deacetylases.

Heltweg B, Dequiedt F, Verdin E, Jung M. Heltweg B, et al. Among authors: jung m. Anal Biochem. 2003 Aug 1;319(1):42-8. doi: 10.1016/s0003-2697(03)00276-8. Anal Biochem. 2003. PMID: 12842105 Free article.

5

Subtype selective substrates for histone deacetylases.

Heltweg B, Dequiedt F, Marshall BL, Brauch C, Yoshida M, Nishino N, Verdin E, Jung M. Heltweg B, et al. Among authors: jung m. J Med Chem. 2004 Oct 7;47(21):5235-43. doi: 10.1021/jm0497592. J Med Chem. 2004. PMID: 15456267 Free article.

6

Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell lines.

Wittich S, Scherf H, Xie C, Heltweg B, Dequiedt F, Verdin E, Gerhäuser C, Jung M. Wittich S, et al. Among authors: jung m. Anticancer Drugs. 2005 Jul;16(6):635-43. doi: 10.1097/00001813-200507000-00008. Anticancer Drugs. 2005. PMID: 15930892 Free article.

7

Chromatin modifications as targets for new anticancer drugs.

Schäfer S, Jung M. Schäfer S, et al. Among authors: jung m. Arch Pharm (Weinheim). 2005 Aug;338(8):347-57. doi: 10.1002/ardp.200500984. Arch Pharm (Weinheim). 2005. PMID: 16041839 Review.

8

Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.

Trapp J, Jochum A, Meier R, Saunders L, Marshall B, Kunick C, Verdin E, Goekjian P, Sippl W, Jung M. Trapp J, et al. Among authors: jung m. J Med Chem. 2006 Dec 14;49(25):7307-16. doi: 10.1021/jm060118b. J Med Chem. 2006. PMID: 17149860

9

Target-based approach to inhibitors of histone arginine methyltransferases.

Spannhoff A, Heinke R, Bauer I, Trojer P, Metzger E, Gust R, Schüle R, Brosch G, Sippl W, Jung M. Spannhoff A, et al. Among authors: jung m. J Med Chem. 2007 May 17;50(10):2319-25. doi: 10.1021/jm061250e. Epub 2007 Apr 14. J Med Chem. 2007. PMID: 17432842

10

A novel arginine methyltransferase inhibitor with cellular activity.

Spannhoff A, Machmur R, Heinke R, Trojer P, Bauer I, Brosch G, Schüle R, Hanefeld W, Sippl W, Jung M. Spannhoff A, et al. Among authors: jung m. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4150-3. doi: 10.1016/j.bmcl.2007.05.088. Epub 2007 Jun 3. Bioorg Med Chem Lett. 2007. PMID: 17570663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,574 results

Search Page

Filters